Arteriovenous Malformations Global Market Report 2025
상품코드:1730780
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
동정맥기형 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 예측 기간의 성장은 헬스케어에 대한 요구의 높아짐, 신경계 약물의 소비 증가, 고령화 인구의 확대 등에 기인하고 있습니다.
최소 침습 수술에 대한 수요가 증가함에 따라 동정맥기형 시장의 확대를 견인할 것으로 예측됩니다. 회복시간을 단축해, 합병증의 리스크를 저하시키고 있습니다. 이 수술은 절개창이 작을수록 조직 손상이 적게 치유 시간이 단축되기 때문에 회복이 빨라지는 것으로 인기가 높아지고 있습니다. 그 때문에 기존 개복 수술에 비해 환자는 더 일찍 일상 생활로 돌아갈 수 있으며 환자와 건강 관리 제공업체 모두에게 선호되는 선택입니다. 동정맥기형은 혈관 내 색전술과 같은 첨단 기술을 사용하여 개복 수술 없이 카테터와 영상 유도 시술을 통해 비정상적인 혈류를 줄이는 방법으로 치료합니다. 예를 들어, 2023년 9월 미국 성형외과학회는 2023년에 2,544만 2,640건의 미용 최소침습 시술이 시행되었으며, 이는 2022년의 2,367만 2,269건보다 7% 증가한 수치라고 보고했습니다.
또한 생명공학에 대한 투자 증가도 동정맥기형 시장의 성장을 가속할 것으로 기대됩니다. 생명공학은 건강관리 관련 제품과 기술을 개발하기 위해 생물학적 프로세스, 생물체, 시스템을 이용하는 것을 포함합니다. 생명공학에 대한 투자는 정밀한 유전자 변형 및 의료 혁신을 가능하게 하는 CRISPR과 같은 유전자 편집 기술의 약진으로 급증하고 있습니다. 동정맥기형은 의료 이미징, 유전자 요법, 침습 요법의 개선을 통해 생명공학에 기여하며, 표적 약물 전달, 혈관 복구 생체재료, AI 지원 진단과 같은 생명공학 솔루션의 개발로 이어집니다. 2024년 8월, 바이오인더스트리협회(BIA)는 영국의 생명과학 바이오테크놀러지 부문이 2024년 1-2분기에 25억 5,000만 달러의 투자를 확보하고 2023년에 조달한 23억 2,000만 달러를 상회했다고 보고했습니다. 이 생명공학 투자 증가는 동정맥기형 시장의 성장을 뒷받침하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계 성장 분석과 전략 분석 프레임워크
세계의 동정맥기형 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 동정맥기형 시장 : 성장률 분석
세계의 동정맥기형 시장 실적 : 규모와 성장(2019-2024년)
세계의 동정맥기형 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 동정맥기형 전체 시장(TAM)
제6장 시장 세분화
세계의 동정맥기형 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
진성 동정맥기형
잠복성 또는 암호성
해면 기형
정맥 기형
혈관종
경막 누공
기타 유형
세계의 동정맥기형 시장 : 진단별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
신체 검사
뇌 스캔
기타
세계의 동정맥기형 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
혈관 내 색전술
신경외과
세계의 동정맥기형 시장 : 연령층별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
성인 환자
소아 환자
세계의 동정맥기형 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 및 클리닉
실험실
기타
세계의 동정맥기형 시장 : 진성 동정맥기형 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
뇌동맥류
척추동맥류
뇌동맥류
사지동맥류
내장동맥류
세계의 동정맥기형 시장 : 잠복성 또는 암호성 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
미세 동정맥기형
잠재 동정맥기형
무증상 동정맥기형
심부심실 동정맥기형
소규모 동정맥기형
세계의 동정맥기형 시장 : 해면 기형 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
대뇌 해면 기형(CCM)
척추 해면 기형
가족성 해면 기형
단발성 해면 기형
다발성 해면 기형
세계의 동정맥기형 시장 : 정맥 기형 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
표재성 정맥기형
심부 정맥기형
혼합 정맥기형
증후군성 정맥기형
청색 고무반점 모반 증후군
세계의 동정맥기형 시장 : 혈관종 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
영아 혈관종
모세 혈관종
소엽 모세혈관종
해면 혈관종
복합 혈관종
세계의 동정맥기형 시장 : 경막 누공 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
두개골 경막 동정맥루(dAVF)
척수 경막 동정맥루
직접 경막 동정맥루
간접 경막 동정맥루
고유량 경막 동정맥루
세계의 동정맥기형 시장 : 기타 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
림프 기형
혼합 혈관 기형
동정맥 동맥류
유전성 출혈성 모세혈관 확대증(HHT) 관련 동정맥기형
희귀 선천성 동정맥기형
제7장 지역별/국가별 분석
세계의 동정맥기형 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 동정맥기형 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
동정맥기형 시장 : 경쟁 구도
동정맥기형 시장 : 기업 프로파일
Johnson And Johnson Services Inc.
Siemens AG
Medtronic Plc
Koninklijke Philips NV
Stryker Corporation
제31장 기타 주요 기업 및 혁신 기업
GE Healthcare Technologies Inc
Cedars-Sinai
Penn Medicine
Terumo Corporation
Eisai Co Ltd
Cook Medical LLC
Elekta AB
Merit Medical Systems Inc.
Penumbra Inc.
Max Healthcare
RWJBarnabas Health
Balt LLC
Booking Health GmbH
Duke University Health System
Shape Memory Medical Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
동정맥기형 시장(2029년) : 새로운 기회를 제공하는 국가
동정맥기형 시장(2029년) : 새로운 기회를 제공하는 부문
동정맥기형 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Arteriovenous malformations are abnormal tangles of blood vessels that form direct connections between arteries and veins, bypassing the normal capillary system. This disruption affects normal blood flow and oxygen circulation, potentially leading to complications. Early diagnosis and appropriate treatment are essential for managing symptoms and reducing the risk of severe complications.
The primary types of arteriovenous malformations include true arteriovenous malformation, occult or cryptic malformations, cavernous malformations, venous malformations, hemangiomas, dural fistulas, and others. True arteriovenous malformation is a congenital vascular anomaly characterized by a direct connection between arteries and veins, bypassing the capillary system. Diagnosis methods include physical examinations, brain scans, and other imaging techniques. Treatment options consist of endovascular embolization and neurosurgery, catering to different age groups such as adult and pediatric patients. These treatments are utilized across various end-users, including hospitals and clinics, research laboratories, and others.
The arteriovenous malformations market research report is one of a series of new reports from The Business Research Company that provides arteriovenous malformations market statistics, including arteriovenous malformations industry global market size, regional shares, competitors with a arteriovenous malformations market share, detailed arteriovenous malformations market segments, market trends and opportunities, and any further data you may need to thrive in the arteriovenous malformations industry. These arteriovenous malformations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The arteriovenous malformations market size has grown strongly in recent years. It will grow from $2.88 billion in 2024 to $3.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historic period can be attributed to the rising prevalence of arteriovenous malformations, the increasing occurrence of neurological and brain disorders, the growing need for improved treatments for rare diseases, enhanced government support for research and development, and the expansion of the business sector.
The arteriovenous malformations market size is expected to see strong growth in the next few years. It will grow to $4.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The projected growth during the forecast period can be attributed to the increasing use of gene therapy, the rising demand for advanced medical technology, the growing need for quality healthcare, the increasing consumption of neurological drugs, and the expansion of the aging population. Key trends expected during this period include advancements in treatment options, innovations in medical technology, progress in microsurgical techniques, developments in catheter technology, and improvements in minimally invasive surgical procedures.
The growing demand for minimally invasive procedures is expected to drive the expansion of the arteriovenous malformations (AVMs) market. Minimally invasive procedures involve surgical or therapeutic interventions that use small incisions or catheter-based techniques to minimize trauma, reduce recovery time, and lower the risk of complications. These procedures are increasingly popular because they enable faster recovery, as smaller incisions cause less tissue damage and shorten healing times. This allows patients to return to their daily routines more quickly compared to traditional open surgeries, making them a preferred choice for both patients and healthcare providers. Arteriovenous malformations are treated using advanced techniques such as endovascular embolization, where catheters and image-guided procedures are employed to reduce abnormal blood flow without the need for open surgery. This approach leads to lower risks, quicker recovery, and improved patient outcomes. For example, in September 2023, the American Society of Plastic Surgeons reported that 25,442,640 cosmetic minimally invasive procedures were performed in 2023, reflecting a 7% increase from the 23,672,269 procedures in 2022. This growth highlights the rising preference for minimally invasive treatments and contributes to the growth of the AVMs market.
Increasing investment in biotechnology is also expected to drive the growth of the arteriovenous malformations market. Biotechnology involves the use of biological processes, organisms, or systems to develop healthcare-related products and technologies. Investment in biotechnology has surged due to breakthroughs in gene editing technologies such as CRISPR, which enable precise genetic modifications and medical innovations. Arteriovenous malformations contribute to biotechnology by improving medical imaging, gene therapy, and minimally invasive treatments, leading to the development of biotechnology-based solutions such as targeted drug delivery, biomaterials for vascular repair, and AI-assisted diagnostics. In August 2024, The BioIndustry Association (BIA) reported that the UK's life sciences and biotechnology sector secured $2.55 billion in investment during the first two quarters of 2024, surpassing the $2.32 billion raised in 2023. This increase in biotechnology investment is helping to drive the growth of the AVMs market.
Companies in the arteriovenous malformations market are also focusing on technological advancements, such as liquid embolic system procedural sets, to enhance treatment procedures and improve patient outcomes. A liquid embolic system procedural set is a pre-assembled, sterilized kit that contains the essential components needed to deliver liquid embolic agents to treat vascular abnormalities such as AVMs. For instance, in March 2024, CERENOVUS Inc., a US-based neurovascular care company under Johnson and Johnson MedTech, introduced the TRUFILL n-BCA liquid embolic system procedural set. This new set includes two configurations and all necessary accessories for preparing and delivering the n-BCA liquid embolic system in a single sterilized package, making procedure preparation more efficient for treating cerebral AVMs.
Major players in the arteriovenous malformations market are Johnson And Johnson Services Inc., Siemens AG, Medtronic Plc, Koninklijke Philips N V, Stryker Corporation, GE Healthcare Technologies Inc, Cedars-Sinai, Penn Medicine, Terumo Corporation, Eisai Co Ltd, Cook Medical LLC, Elekta AB, Merit Medical Systems Inc., Penumbra Inc., Max Healthcare, RWJBarnabas Health, Balt LLC, Booking Health GmbH, Duke University Health System, Shape Memory Medical Inc.
North America was the largest region in the arteriovenous malformations market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in arteriovenous malformations report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the arteriovenous malformations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The arteriovenous malformations market consists of revenues earned by entities by providing services such as minimally invasive embolization, post-procedure rehabilitation, and telemedicine consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The arteriovenous malformations market also includes sales of embolization devices, neurovascular catheters, liquid embolic agents, microsurgical instruments, and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Arteriovenous Malformations Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on arteriovenous malformations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for arteriovenous malformations ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The arteriovenous malformations market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: True Arteriovenous Malformation; Occult Or Cryptic; Cavernous Malformations; Venous Malformation; Hemangioma; Dural Fistula; Other Types
2) By Diagnosis: Physical examination; Brain Scans; Other Diagnosis
3) By Treatment: Endovascular Embolization; Neurosurgery
4) By Age Group: Adult Patients; Pediatric Patients
5) By End-User: Hospitals And Clinics; Research laboratories; Other End-Users
3. Arteriovenous Malformations Market Trends And Strategies
4. Arteriovenous Malformations Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Arteriovenous Malformations Growth Analysis And Strategic Analysis Framework
5.1. Global Arteriovenous Malformations PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Arteriovenous Malformations Market Growth Rate Analysis
5.4. Global Arteriovenous Malformations Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Arteriovenous Malformations Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Arteriovenous Malformations Total Addressable Market (TAM)
6.1. Global Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
True Arteriovenous Malformation
Occult Or Cryptic
Cavernous Malformations
Venous Malformation
Hemangioma
Dural Fistula
Other Types
6.2. Global Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Physical examination
Brain Scans
Other Diagnosis
6.3. Global Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Endovascular Embolization
Neurosurgery
6.4. Global Arteriovenous Malformations Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adult Patients
Pediatric Patients
6.5. Global Arteriovenous Malformations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Research laboratories
Other End-Users
6.6. Global Arteriovenous Malformations Market, Sub-Segmentation Of True Arteriovenous Malformation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pial AVMs
Spinal AVMs
Brain AVMs
Extremity AVMs
Visceral AVMs
6.7. Global Arteriovenous Malformations Market, Sub-Segmentation Of Occult or Cryptic Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Micro-AVMs
Hidden AVMs
Asymptomatic AVMs
Deep-Seated AVMs
Small-Scale AVMs
6.8. Global Arteriovenous Malformations Market, Sub-Segmentation Of Cavernous Malformations Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cerebral Cavernous Malformations (CCMs)
Spinal Cavernous Malformations
Familial Cavernous Malformations
Solitary Cavernous Malformations
Multiple Cavernous Malformations
6.9. Global Arteriovenous Malformations Market, Sub-Segmentation Of Venous Malformation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Superficial Venous Malformations
Deep Venous Malformations
Mixed Venous Malformations
Syndromic Venous Malformations
Blue Rubber Bleb Nevus Syndrome
6.10. Global Arteriovenous Malformations Market, Sub-Segmentation Of Hemangioma Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infantile Hemangiomas
Capillary Hemangiomas
Lobular Capillary Hemangiomas
Cavernous Hemangiomas
Compound Hemangiomas
6.11. Global Arteriovenous Malformations Market, Sub-Segmentation Of Dural Fistula Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cranial Dural Arteriovenous Fistula (dAVF)
Spinal Dural Arteriovenous Fistula
Direct Dural AV Fistula
Indirect Dural AV Fistula
High-Flow Dural Fistula
6.12. Global Arteriovenous Malformations Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
